Summary
1. We studied the effects of BQ-123, a selective ETA receptor antagonist, on125I-endothelin-1 (125I-ET-1) binding to cell surface receptors in surgically excised human meningiomas and on ET-1-induced DNA synthesis in cultured human meningioma cellsin vitro, using a quantitative receptor autoradiographic technique with radioluminography and3H-thymidine incorporation, respectively.
2. All of the human meningiomas expressed high-affinity binding sites for125I-ET-1, regardless of differences in histological subtypes (K d=2.6±0.2 nM,B max=374±93 fmol/mg; mean ± SE;n=9).
3. BQ-123 competed for125I-ET-1 binding to sections of meningiomas with IC50s of 3.2±0.9×10−7 M, and 10−4 M BQ-123 displaced 80% of the binding.
4. ET-1 significantly stimulated DNA synthesis in cultured human meningioma cells, up to 170% of the basal level in the presence of 10−9 M ET-1. BQ-123 inhibited ET-1 (10−9 M)-induced DNA synthesis in meningioma cells, in a dose-dependent manner, and 10−5 M BQ-123 reduced it to 120% of the basal level.
5. The number of meningioma cells determined after 4 days in culture was dose dependently increased in the presence of ET-1 (10−9 and 10−7 M). The growth rate of meningioma cells, incubated with 10−9 M ET-1, was reduced by 50% in the presence of 10−7 M BQ-123.
6. Our data suggest that (a) human meningioma cells express a large number of ETA endothelin receptors, with a small proportion of non-ETA receptors linked to proliferation of the cells, and (b) ET receptor antagonists, including BQ-123, might prove to be effective treatment for patients with meningioma.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Amemiya, Y., and Miyahara, J. (1988). Imaging plate illuminates many fields.Nature 33689–90.
Arai, H., Hori, S., Aramori, I., Ohkubo, H., and Nakanishi, S. (1990). Cloning and expression of a cDNA encoding an endothelin receptor.Nature 348730–732.
Clozel, M., Breu, V., Burri, K., Cassal, J. M., Fischli, W., Gray, G. A., Hirth, G., Loffler, B. M., Muller, M., Neidhart, W., and Ramuz, H. (1993). Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist.Nature 365759–761.
Couraud, P. O., Durieu-Trautmann, O., Le Nguyen, D., Marin, P., Glibert, F., and Strosberg, A. D. (1991). Functional endothelin-1 receptors in rat astrocytoma C6.Eur. J. Pharmacol. Mol. Pharmacol. Sect. 206191–198.
Economo, K., MacDonald, P. C., and Casey, M. L. (1992). Endothelin-1 gene expression and biosynthesis in human endometrial HEC-1A cancer cells.Cancer Res. 52554–557.
Eguchi, S., Hirata, Y., Ihara, M., Yano, M., and Marumo, F. (1992). A novel ETA antagonist (BQ-123) inhibits endothelin-1 induced phosphoinositide breakdown and DNA synthesis in rat vascular smooth muscle cells.FEBS Lett. 302243–246.
Elshourbagy, N. A., Korman, D. R., Wu, H. L., Sylvester, D. R., Lee, J. A., Nuthalaganti, P., Bergsma, D. J., Kumar, C. S., and Nambi, P. (1993). Molecular characterization and regulation of the human endothelin receptors.J. Biol. Chem. 2683873–3879.
Emori, T., Hirata, Y., and Marumo, F. (1990). Specific receptors for endothelin-3 in cultured bovine endothelial cells and its cellular mechanism of action.FEBS Lett. 263261–264.
Godfraind, T. (1993). Evidence for heterogeneity of endothelin receptor distribution in human coronary artery.Br. J. Pharmacol. 1101201–1205.
Hagiwara, H., Nagasawa, T., Yamamoto, T., Lodhi, K. M., Ito, T., Takemura, N., and Hirose, S. (1993). Immunochemical characterization and localization of endothelin ETB receptor.Am. J. Physiol. 33R777-R783.
Hori, S., Komatsu, Y., Shigemoto, R., Mizuno, M., and Nakanishi, S. (1992). Distinct tissue distribution and cellular localization of two messenger ribonucleic acids encoding different subtypes of rat endothelin receptors.Endocrinology 1301885–1895.
Ihara, M., Noguchi, K., Saeki, T., Fukuroda, T., Tsuchida, S., Kimura, S., Fukami, T., Ishikawa, K., Nishikibe, M., and Yano, M. (1992a). Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor.Life Sci. 50247–255.
Ihara, M., Saeki, T., Fukuroda, T., Kimura, S., Ozaki, S., Patel, A. C., and Yano, M. (1992b). A novel radioligand [125I]BQ-3020 selective for endothelin (ETB) receptors.Life Sci. 51PL47-PL52.
Ishibashi, M., Fujita, M., Nagai, K., Kako, M., Furue, H., Haku, E., Osamura, Y., and Yamaji, T. (1993). Production and secretion of endothelin by hepatocellular carcinoma.J. Clin. Endocrinol. Metab. 76378–383.
Kajikawa, H., Kawamoto, K., Herz, F., Wolley, R. C., Hirano, A., and Koss, L. G. (1978). Flow-through cytometry of meningiomas and cultured meningioma cells.Acta Neuropathol. 44183–187.
Karet, F. E., Kuc, R. E., and Davenport, A. P. (1993). Novel ligands BQ123 and BQ3020 characterize endothelin receptor subtypes ETA and ETB in human kidney.Kidney Int. 4436–42.
Kitagawa, N., Tsutsumi, K., Niwa, M., Himeno, A., Yamashita, K., Shibata, S., Taniyama, K., Kurihara, M., Kawano, T., Yasunaga, A., and Shibata, S. (1994). Expression of a functional endothelin (ETA) receptor in human meningiomas.J. Neurosurg. 801723–1731.
Kobayashi, M., Ihara, M., Sato, N., Saeki, T., Ozaki, S., Ikemoto, F., and Yano, M. (1993). A novel ligand, [125I]BQ-123, reveals the localization of endothelin ETB receptors.Eur. J. Pharmacol. 23595–100.
Kohzuki, M., Chai, S. Y., Paxinos, G., Karavas, A., Casley, D. J., Johnston, C. I., and Mendelsohn, F. A. O. (1991). Localization and characterization of endothelin receptor binding sites in the rat brain visualized by in vitro autoradiography.Neuroscience 42245–260.
Komuro, I., Kurihara, H., Sugiyama, T., Takaku, F., and Yazaki, Y. (1988). Endothelin stimulates c-fos and c-mic expression and proliferation of vascular smooth muscle cells.FEBS Lett. 238249–252.
Kurihara, M., Ochi, A., Kawaguchi, T., Tokunaga, Y., Kataoka, Y., Niwa, M., and Mori, K. (1989a). Presence of endothelin receptor in human glioma.Neuroimmunol. Res. 2173–177 (in Japanese; English abstract).
Kurihara, M., Tokunaga, Y., Tsutsumi, K., Kawaguchi, T., Shigematsu, K., Niwa, M., and Mori, K. (1989b). Characterization of insulin-like growth factor I and epidermal growth factor receptors in meningioma.J. Neurosurg. 71538–544.
Kurihara, M., Ochi, A., Kawaguchi, T., Niwa, M., Kataoka, Y., Mori, K. (1990). Localization and characterization of endothelin receptors in human gliomas: A growth factor?Neursurgery 27275–281.
Kusuhara, M., Yamaguchi, K., Nagasaki, K., Hayashi, C., Suzaki, A., Hori, S., Handa, S., Nakamura, Y., and Abe, K. (1990). Production of endothelin in human cancel cell lines.Cancer Res. 503257–3261.
Kusuhara, M., Yamaguchi, K., Kuranami, M., Suzaki, A., Ishikawa, S., Moon, H., Adachi, I., Hori, S., and Handa, S. (1992). Stimulation of anchorage-independent cell growth by endothelin in NRK 49F cells.Cancer Res. 523011–3014.
MacCumber, M. W., Ross, C. A., and Snyder, S. H. (1990). Endothelin in brain: Receptors, mitogenesis, and biosynthesis in glial cells.Proc. Natl. Acad. Sci. USA 872359–2363.
McPherson, G. A. (1985). Analysis of radioligand binding experiments: A collection of computer program for the IBM PC.J. Pharmacol. Meth. 14213–228.
Molenaar, P., O'Reilly, G., Sharkey, A., Kuc, R. E., Harding, D. P., Plumpton, C., Gresham, G. A., and Davenport, A. P. (1993). Characterization and localization of endothelin receptor subtypes in the human atrioventricular conduction system and myocardium.Circ. Res. 72526–538.
Moolenaar, W. H. (1986). Effects of growth factors on intracellular pH regulation.Annu. Rev. Physiol. 48363–376.
Munson, P. J., and Rodbard, D. (1980). LIGAND: A versatile computerized approach for characterization of ligand-binding systems.Anal. Biochem. 107202–239.
Nakamichi, K., Ihara, M., Kobayashi, M., Saeki, T., Ishikawa, K., and Yano, M. (1992). Differential distribution of endothelin receptor subtypes in pulmonary tissues revealed by the novel selective ligand BQ-123 and [Ala1,3,11,15]ET-1.Biochem. Biophys. Res. Commun. 182144–150.
Niwa, M., Kawaguchi, T., Himeno, A., Fujimoto, M., Kurihara, M., Yamashita, K., Kataoka, Y., Shigematsu, K., and Taniyama, K. (1992). Specific binding sites for125I-endothelin-1 in the porcine and human spinal cord.Eur. J. Pharmacol. Mol. Pharmacol. Sect. 225281–289.
Ohlstein, E. H., Arleth, A., Bryan, H., Elliot, J. D., and Sung, C. P. (1992). The selective endothelin ETA receptor antagonist BQ123 antagonizes endothelin-1 mediated mitogenesis.Eur. J. Pharmacol. Mol. Pharmacol. Sect. 225347–350.
Ohnishi-Suzaki, A., Yamaguchi, K., Kusuhara, M., Adachi, I., Abe, K., and Kimura, S. (1990). Comparison of biological activities of endothelin-1, -2 and -3 in murine and human fibroblast cell lines.Biochem. Biophys. Res. Commun. 166608–614.
Russel, W. E., Van Wyk, J. J., and Pledger, W. J. (1984). Inhibition of the mitogenic effects of plasma by a monoclonal antibody to somatomedin C.Proc. Natl. Acad. Sci. USA 812389–2392.
Sakurai, T., Yanagisawa, M., Takuwa, Y., Miyazaki, H., Kimura, S., Goto, K., and Masaki, T. (1990). Cloning of a CDNA encoding a non-isopeptide-selective subtype of the endothelin receptor.Nature 348732–735.
Sakurai, T., Yanagisawa, M., and Masaki, T. (1992). Molecular characterization of endothelin receptors.Trends Pharmacol. Sci. 13103–108.
Sato, T., Niwa, M., Himeno, A., Tsutsumi, K., and Amemiya, T. (1993). Quantitative receptor autoradiographic analysis for angiotensin II receptors in bovine retinal microvessels: Quantitation with radioluminography.Cell. Mol. Neurobiol. 13233–245.
Schoeffter, P., and Randriantsoa, A. (1993). Differences between endothelin receptors mediating contraction of guinea-pig aorta and pig coronary artery.Eur. J. Pharmacol. 249199–206.
Schoeffter, P., Randriantsoa, A., Jost, B., and Bruttel, K. (1993). Comparative effects of the two endothelin ETA receptor antagonists, BQ-123 and FR139317, on endothelin-1-induced contraction in guinea-pig iliac artery.Eur. J. Pharmacol. 241165–169.
Schuldiner, S., and Rozengurt, E. (1982). Na+/H+ antiport in Swiss 3T3 cells: mitogenic stimulation leads to cytoplasmic alkalinization.Proc. Natl. Acad. Sci. USA 797778–7782.
Shichiri, M., Hirata, Y., Nakajima, T., Ando, K., Imai, T., Yanigisawa, M., Masaki, T., and Marumo, F. (1991). Endothelin-1 is an autocrine/paracrine growth factor for human cancer cell lines.J. Clin. Invest. 871867–1871.
Simonson, M. S., Wann, S., Mene, P., Dubyak, G. R., Kester, M., Nakazato, Y., Sedor, J. R., and Dunn, M. J. (1989). Endothelin stimulates phospholipase C, Na+/H+ exchange, c-fos expression, and mitogenesis in rat mesangial cells.J. Clin. Invest. 83708–712.
Sudjarwo, S. A., Hori, M., Takai, M., Urade, Y., Okada, T., and Karaki, H. (1993). A novel subtype of endothelin B receptor mediating contraction in swine pulmonary vein.Life Sci. 53431–437.
Suzuki, N., Matsumoto, H., Kitada, C., Kimura, S., and Fujino, M. (1989). Production of endothelin-1 and big-endothelin-1 by tumor cells with epithelial-like morphology.J. Biochem. 106736–741.
Takuwa, N., Takuwa, Y., Yanagisawa, M., Yamashita, K., and Masaki, T. (1989). A novel vasoactive peptide endothelin stimulates mitogenesis through inositol lipid turnover in Swiss 3T3 fibroblasts.J. Biol. Chem. 2647856–7861.
Tsutsumi, K., and Saavedra, J. M. (1992). Heterogeneity of angiotensin II AT2 receptors in the rat brain.Mol. Pharmacol. 41290–297.
Tsutsumi, K., Kitagawa, N., Niwa, M., Himeno, A., Taniyama, K., and Shibata, S. (1994). Effect of suramin on125-I insulin-like growth factor I binding to human meningiomas and on proliferation of meningioma cells.J. Neurosurg. 80502–509.
Vigne, P., Marsault, R., Breittmayer, J. P., and Frelin, C. (1990). Endothelin stimulates phosphatidylinositol hydrolysis and DNA synthesis in brain capillary endothelial cells.Biochem. J. 266415–420.
Vigne, P., Ladoux, A., and Frelin, C. (1991). Endothelins activate Na+/H+ exchange in brain capillary endothelial cells via high affinity endothelin-3 receptor that is not coupled to phospholipase C.J. Biol. Chem. 2665925–5928.
Weisman, A. S., Villemura, J. G., and Kelly, P. A. (1986). Regulation of DNA synthesis and growth of cells derived from primary human meningiomas.Cancer Res. 462545–2550.
Wilkes, L. C., and Boarder, M. R. (1991). Characterization of endothelin receptors on a human neuroblastoma cell line: Evidence for the ETA subtypes.Br. J. Pharmacol. 104750–754.
Yamasaki, H., Niwa, M., Yamashita, K., Kataoka, Y., Shigematsu, K., Hashiba, K., and Ozaki, M. (1989). Specific125I-endothelin-1 binding sites in the atrioventricular node of the porcine heart.Eur. J. Pharmacol. 168247–250.
Yanai, K., Ryu, J. H., Watanabe, T., Iwata, R., and Ido, T. (1992). Receptor autoradiography with11C and [3H]-labelled ligands visualized by imaging plates.NeuroReport 3961–964.
Yin, J., Lee, A., and Howells, R. D. (1992). Stimulation of c-fos and c-jun gene expression and down-regulation of proenkephalin gene expression in C6 glioma cells by endothelin-1.Mol. Brain. Res. 14213–220.
Zhang, W., Sakai, N., Yamada, H., Fu, T., and Nozawa, T. (1990). Endothelin-1 induces intracellular calcium rise and inositol 1,4,5-triphosphate formation in cultured rat and human glioma cells.Neurosci. Lett. 112199–204.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kitagawa, N., Tsutsumi, K., Niwa, M. et al. A selective endothelin ETA antagonist, BQ-123, inhibits125I-endothelin-1 (125I-ET-1) binding to human meningiomas and antagonizes ET-1-induced proliferation of meningioma cells. Cell Mol Neurobiol 14, 105–118 (1994). https://doi.org/10.1007/BF02090779
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02090779